Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1998 2
1999 1
2000 2
2001 5
2002 11
2003 6
2004 4
2005 3
2006 5
2007 11
2008 7
2009 9
2010 17
2011 10
2012 8
2013 9
2014 11
2015 8
2016 17
2017 18
2018 22
2019 14
2020 26
2021 13
2022 23
2023 9

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Results by year

Filters applied: . Clear all
Page 1
Incidence of newly diagnosed diabetes after Covid-19.
Rathmann W, Kuss O, Kostev K. Rathmann W, et al. Among authors: kuss o. Diabetologia. 2022 Jun;65(6):949-954. doi: 10.1007/s00125-022-05670-0. Epub 2022 Mar 16. Diabetologia. 2022. PMID: 35292829 Free PMC article.
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.
Zaharia OP, Strassburger K, Strom A, Bönhof GJ, Karusheva Y, Antoniou S, Bódis K, Markgraf DF, Burkart V, Müssig K, Hwang JH, Asplund O, Groop L, Ahlqvist E, Seissler J, Nawroth P, Kopf S, Schmid SM, Stumvoll M, Pfeiffer AFH, Kabisch S, Tselmin S, Häring HU, Ziegler D, Kuss O, Szendroedi J, Roden M; German Diabetes Study Group. Zaharia OP, et al. Among authors: kuss o. Lancet Diabetes Endocrinol. 2019 Sep;7(9):684-694. doi: 10.1016/S2213-8587(19)30187-1. Epub 2019 Jul 22. Lancet Diabetes Endocrinol. 2019. PMID: 31345776
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial.
Kahl S, Gancheva S, Straßburger K, Herder C, Machann J, Katsuyama H, Kabisch S, Henkel E, Kopf S, Lagerpusch M, Kantartzis K, Kupriyanova Y, Markgraf D, van Gemert T, Knebel B, Wolkersdorfer MF, Kuss O, Hwang JH, Bornstein SR, Kasperk C, Stefan N, Pfeiffer A, Birkenfeld AL, Roden M. Kahl S, et al. Among authors: kuss o. Diabetes Care. 2020 Feb;43(2):298-305. doi: 10.2337/dc19-0641. Epub 2019 Sep 20. Diabetes Care. 2020. PMID: 31540903 Clinical Trial.
Collider Bias in Observational Studies.
Tönnies T, Kahl S, Kuss O. Tönnies T, et al. Among authors: kuss o. Dtsch Arztebl Int. 2022 Feb 18;119(7):107-122. doi: 10.3238/arztebl.m2022.0076. Dtsch Arztebl Int. 2022. PMID: 34939918 Free PMC article. Review.
BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy.
Bönhof GJ, Sipola G, Strom A, Herder C, Strassburger K, Knebel B, Reule C, Wollmann JC, Icks A, Al-Hasani H, Roden M, Kuss O, Ziegler D. Bönhof GJ, et al. Among authors: kuss o. BMJ Open. 2022 Feb 3;12(2):e057142. doi: 10.1136/bmjopen-2021-057142. BMJ Open. 2022. PMID: 35115359 Free PMC article. Clinical Trial.
232 results